TRDA Entrada Therapeutics, Inc.
Nasdaq · SEC CIK 1689375 · EDGAR
- Bought, last 12 months
- $1.64M 3 purchases by 3 insiders
- Sold, last 12 months
- $15.10M 21 sales by 7 insiders
- Filings on record
- 221 since 2021-11-01, latest 2026-09-09 19:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| PARMAR KUSH | Dir, 10% | — | $3.65M |
| MPM BIOVENTURES 2018, L.P. | 10% | — | $3.60M |
| MPM BioVentures 2014, L.P. | 10% | — | $3.60M |
| 5AM Ventures V, L.P. | 10% | — | $3.00M |
| Baker Bros. Advisors (GP) LLC | 10% | $1.35M | — |
| WENTWORTH KORY JAMES | CFO | — | $433.6K |
| Dowden Nathan J | Pres, COO | — | $425.7K |
| Sethuraman Natarajan | Pres, Research, Develop | — | $398.8K |
| BAKER FELIX | 10% | $261.8K | — |
| Zeiher Bernhardt G | Dir | $29.3K | — |
Transactions 229
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-09 19:24 | 2026-09-04+ | TRDA | MPM BIOVENTURES 2018, L.P. | 10% | S - Sale | $7.33 | -259.8K | 3.89M | -6% | -$1.91M |
| MI | 2026-09-09 19:23 | 2026-09-04+ | TRDA | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.33 | -259.8K | 3.89M | -6% | -$1.91M |
| MI | 2026-09-03 19:21 | 2026-09-01+ | TRDA | MPM BIOVENTURES 2018, L.P. | 10% | S - Sale | $7.14 | -86.5K | 4.14M | -2% | -$617.4K |
| MI | 2026-09-03 19:21 | 2026-09-01+ | TRDA | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.14 | -86.5K | 4.14M | -2% | -$617.4K |
| 2026-09-03 17:19 | 2026-09-02 | TRDA | Doshi Dipal | CEO, Dir | F - Tax | $7.14 | -8,724 | 517.3K | -2% | -$62.3K | |
| 2026-09-03 17:18 | 2026-09-02 | TRDA | Dowden Nathan J | Pres, COO | F - Tax | $7.14 | -2,528 | 196.1K | -1% | -$18.1K | |
| 2026-09-03 17:16 | 2026-09-02 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | F - Tax | $7.14 | -2,079 | 214.2K | -1.0% | -$14.9K | |
| 2026-09-03 17:15 | 2026-09-02 | TRDA | WENTWORTH KORY JAMES | CFO | F - Tax | $7.14 | -1,733 | 117.3K | -1% | -$12.4K | |
| MI | 2026-08-31 18:26 | 2026-08-27+ | TRDA | MPM BIOVENTURES 2018, L.P. | 10% | S - Sale | $7.08 | -86.9K | 4.23M | -2% | -$615.8K |
| MI | 2026-08-31 18:25 | 2026-08-27+ | TRDA | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.08 | -86.9K | 4.23M | -2% | -$615.8K |
| MI | 2026-08-26 21:28 | 2026-08-24+ | TRDA | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.36 | -62.7K | 4.32M | -1% | -$461.5K |
| MI | 2026-08-26 21:27 | 2026-08-24+ | TRDA | MPM BIOVENTURES 2018, L.P. | 10% | S - Sale | $7.36 | -62.7K | 4.32M | -1% | -$461.5K |
| MI | 2026-08-10 19:54 | 2026-08-06+ | TRDA | PARMAR KUSH | Dir | S - Sale | $6.95 | -155.3K | 2.69M | -5% | -$1.08M |
| M | 2026-08-10 19:52 | 2026-08-06+ | TRDA | 5AM Ventures V, L.P. | 10% | S - Sale | $6.88 | -62.8K | 2.78M | -2% | -$431.8K |
| M | 2026-08-03 17:32 | 2026-07-30+ | TRDA | 5AM Ventures V, L.P. | 10% | S - Sale | $6.93 | -116.5K | 2.85M | -4% | -$807.0K |
| MI | 2026-08-03 17:26 | 2026-07-30+ | TRDA | PARMAR KUSH | Dir, 10% | S - Sale | $6.93 | -116.5K | 2.85M | -4% | -$807.0K |
| I | 2026-05-21 16:31 | 2026-05-20 | TRDA | Zeiher Bernhardt G | Dir | P - Purchase | $5.86 | +5,000 | 5,000 | New | +$29.3K |
| T | 2026-05-04 19:25 | 2026-05-04 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | S - Sale | $15.39 | -25.9K | 216.3K | -11% | -$398.8K |
| DT | 2026-05-04 19:24 | 2026-05-04 | TRDA | Dowden Nathan J | Pres, COO | M - OptEx | $1.74 | +15.0K | 213.6K | +8% | +$26.1K |
| DT | 2026-05-04 19:24 | 2026-05-04 | TRDA | Dowden Nathan J | Pres, COO | S - Sale+OE | $15.33 | -15.0K | 198.6K | -7% | -$230.0K |
| T | 2026-04-02 16:39 | 2026-04-01 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $12.95 | -2,500 | 119.0K | -2% | -$32.4K |
| M | 2026-03-11 | 2026-03-09+ | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $13.01 | -16.5K | 121.5K | -12% | -$214.4K |
| M | 2026-03-11 | 2026-03-09+ | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $13.04 | -15.0K | 198.6K | -7% | -$195.8K |
| 2026-03-06 | 2026-03-04 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $12.25 | -7,988 | 138.0K | -5% | -$97.9K | |
| D | 2026-03-03 | 2026-03-01 | TRDA | Dowden Nathan J | Pres, COO | A - Grant | $0.00 | +55.8K | 234.9K | +31% | $0 |
| DM | 2026-03-03 | 2026-03-02+ | TRDA | Dowden Nathan J | Pres, COO | F - Tax | $11.73 | -21.3K | 213.6K | -9% | -$249.3K |
| DM | 2026-03-03 | 2026-03-02+ | TRDA | WENTWORTH KORY JAMES | CFO | F - Tax | $11.73 | -8,651 | 146.0K | -6% | -$101.4K |
| D | 2026-03-03 | 2026-03-01 | TRDA | WENTWORTH KORY JAMES | CFO | A - Grant | $0.00 | +44.6K | 154.6K | +41% | $0 |
| D | 2026-03-03 | 2026-03-01 | TRDA | Doshi Dipal | CEO, Dir | A - Grant | $0.00 | +139.4K | 555.1K | +34% | $0 |
| DM | 2026-03-03 | 2026-03-02+ | TRDA | Doshi Dipal | CEO, Dir | F - Tax | $11.73 | -29.1K | 526.0K | -5% | -$340.6K |
| D | 2026-03-03 | 2026-03-01 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | A - Grant | $0.00 | +55.8K | 253.7K | +28% | $0 |
| DM | 2026-03-03 | 2026-03-02+ | TRDA | Sethuraman Natarajan | Pres, Research, Develop | F - Tax | $11.73 | -11.5K | 242.2K | -5% | -$134.6K |
| MI | 2025-11-24 | 2025-11-20 | TRDA | BAKER FELIX | 10% | P - Purchase | $9.07 | +28.9K | 380.2K | +8% | +$261.8K |
| 2025-11-24 | 2025-11-21 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $9.98 | -8,910 | 110.0K | -7% | -$88.9K | |
| I | 2025-11-18 | 2025-11-14 | TRDA | PARMAR KUSH | Dir, 10% | S - Sale | $8.80 | -200.0K | 2.96M | -6% | -$1.76M |
| 2025-11-18 | 2025-11-14 | TRDA | 5AM Ventures V, L.P. | 10% | S - Sale | $8.80 | -200.0K | 2.96M | -6% | -$1.76M | |
| MI | 2025-11-12 | 2025-11-10+ | TRDA | Baker Bros. Advisors (GP) LLC | 10% | P - Purchase | $7.60 | +178.0K | 367.8K | +94% | +$1.35M |
| 2025-09-04 | 2025-09-02 | TRDA | Dowden Nathan J | Pres, COO | F - Tax | $5.43 | -1,746 | 179.1K | -1.0% | -$9,481 | |
| 2025-09-04 | 2025-09-02 | TRDA | WENTWORTH KORY JAMES | CFO | F - Tax | $5.43 | -1,734 | 118.9K | -1% | -$9,416 | |
| 2025-09-04 | 2025-09-02 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | F - Tax | $5.43 | -1,760 | 197.9K | -0.9% | -$9,557 | |
| 2025-09-04 | 2025-09-02 | TRDA | Doshi Dipal | CEO, Dir | F - Tax | $5.43 | -8,723 | 415.7K | -2% | -$47.4K | |
| MI | 2025-07-11 | 2025-07-09 | TRDA | PARMAR KUSH | Dir, 10% | S - Sale | $7.50 | -27.0K | 1.09M | -2% | -$202.5K |
| 2025-07-11 | 2025-07-09 | TRDA | 5AM Opportunities I, L.P. | 10% | S - Sale | $7.50 | -20.1K | 3.16M | -0.6% | -$150.5K | |
| I | 2025-07-11 | 2025-07-09 | TRDA | 5AM Opportunities I, L.P. | 10% | S - Sale | $7.50 | -6,935 | 1.09M | -0.6% | -$52.0K |
| MI | 2025-07-01 | 2025-06-27+ | TRDA | PARMAR KUSH | Dir, 10% | S - Sale | $6.93 | -125.0K | 3.22M | -4% | -$866.5K |
| MI | 2025-07-01 | 2025-06-27+ | TRDA | Schwab Andrew J. | 10% | S - Sale | $6.93 | -32.1K | 1.11M | -3% | -$222.6K |
| M | 2025-07-01 | 2025-06-27+ | TRDA | Schwab Andrew J. | 10% | S - Sale | $6.93 | -92.9K | 3.20M | -3% | -$643.9K |
| MA | 2025-06-18 | 2024-05-13+ | TRDA | KIM PETER S | Dir | P - Purchase | $14.63 | +50.0K | 92.4K | +118% | +$731.8K |
| D | 2025-04-04 | 2025-04-03 | TRDA | WENTWORTH KORY JAMES | CFO | M - OptEx | $2.10 | +11.1K | 120.7K | +10% | +$23.4K |
| 2025-03-19 | 2025-03-17 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $10.67 | -1,784 | 109.5K | -2% | -$19.0K | |
| D | 2025-03-04 | 2025-03-03 | TRDA | Doshi Dipal | CEO, Dir | F - Tax | $11.68 | -17.6K | 424.4K | -4% | -$205.2K |
| D | 2025-03-04 | 2025-03-01 | TRDA | Doshi Dipal | CEO, Dir | A - Grant | $0.00 | +116.2K | 442.0K | +36% | $0 |
| D | 2025-03-04 | 2025-03-03 | TRDA | WENTWORTH KORY JAMES | CFO | F - Tax | $11.68 | -4,929 | 111.3K | -4% | -$57.6K |
| D | 2025-03-04 | 2025-03-01 | TRDA | WENTWORTH KORY JAMES | CFO | A - Grant | $0.00 | +42.4K | 116.2K | +57% | $0 |
| D | 2025-03-04 | 2025-03-03 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | F - Tax | $11.68 | -6,138 | 199.7K | -3% | -$71.7K |
| D | 2025-03-04 | 2025-03-01 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | A - Grant | $0.00 | +60.8K | 205.8K | +42% | $0 |
| D | 2025-03-04 | 2025-03-01 | TRDA | Dowden Nathan J | Pres, COO | A - Grant | $0.00 | +60.8K | 185.9K | +49% | $0 |
| D | 2025-03-04 | 2025-03-03 | TRDA | Dowden Nathan J | Pres, COO | F - Tax | $11.68 | -5,144 | 180.8K | -3% | -$60.1K |
| MI | 2024-12-12 | 2024-12-10+ | TRDA | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | 10% | S - Sale | $20.51 | -44.7K | 4.38M | -1% | -$917.1K |
| MI | 2024-12-12 | 2024-12-10+ | TRDA | MPM BioVentures 2018 GP LLC | 10% | S - Sale | $20.51 | -44.7K | 4.38M | -1% | -$917.1K |
| DM | 2024-12-03 | 2024-11-29+ | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale+OE | $20.00 | -6,000 | 73.8K | -8% | -$120.0K |
| DM | 2024-12-03 | 2024-11-29+ | TRDA | WENTWORTH KORY JAMES | CFO | M - OptEx | $2.10 | +6,000 | 74.8K | +9% | +$12.6K |
| M | 2024-12-03 | 2024-11-29+ | TRDA | Sethuraman Natarajan | Pres, Research, Develop | S - Sale | $20.18 | -15.9K | 156.7K | -9% | -$320.6K |
| D | 2024-11-13 | 2024-11-11 | TRDA | WENTWORTH KORY JAMES | CFO | M - OptEx | $2.10 | +6,000 | 82.5K | +8% | +$12.6K |
| D | 2024-11-13 | 2024-11-11 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale+OE | $19.98 | -8,637 | 73.8K | -10% | -$172.6K |
| M | 2024-11-13 | 2024-11-11+ | TRDA | Sethuraman Natarajan | Pres, Research, Develop | S - Sale | $20.03 | -4,109 | 160.9K | -2% | -$82.3K |
| M | 2024-11-06 | 2024-11-04+ | TRDA | Sethuraman Natarajan | Pres, Research, Develop | S - Sale | $18.62 | -18.2K | 177.3K | -9% | -$339.3K |
| 2024-10-18 | 2024-10-16 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | S - Sale | $18.00 | -600 | 183.2K | -0.3% | -$10.8K | |
| 2024-09-30 | 2024-09-26 | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $16.00 | -847 | 125.1K | -0.7% | -$13.6K | |
| M | 2024-09-10 | 2024-09-06+ | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $15.09 | -2,303 | 126.0K | -2% | -$34.8K |
| 2024-09-10 | 2024-09-09 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $14.97 | -3,195 | 76.5K | -4% | -$47.8K | |
| M | 2024-09-10 | 2024-09-06+ | TRDA | Sethuraman Natarajan | CSO | S - Sale | $15.12 | -3,242 | 186.5K | -2% | -$49.0K |
| M | 2024-09-05 | 2024-09-03+ | TRDA | Sethuraman Natarajan | CSO | F - Tax | $15.63 | -1,756 | 188.2K | -0.9% | -$27.4K |
| M | 2024-09-05 | 2024-09-03+ | TRDA | WENTWORTH KORY JAMES | CFO | F - Tax | $15.63 | -1,731 | 80.8K | -2% | -$27.1K |
| M | 2024-09-05 | 2024-09-03+ | TRDA | Doshi Dipal | CEO, Dir | F - Tax | $15.63 | -8,722 | 332.1K | -3% | -$136.3K |
| M | 2024-09-05 | 2024-09-03+ | TRDA | Dowden Nathan J | Pres, COO | F - Tax | $15.63 | -1,808 | 129.6K | -1% | -$28.3K |
| D | 2024-08-20 | 2024-08-16 | TRDA | Dowden Nathan J | Pres, COO | M - OptEx | $1.74 | +20.0K | 157.2K | +15% | +$34.8K |
| DM | 2024-08-20 | 2024-08-16 | TRDA | Dowden Nathan J | Pres, COO | S - Sale+OE | $16.27 | -27.1K | 130.1K | -17% | -$440.8K |
| M | 2024-07-16 | 2024-07-12+ | TRDA | Sethuraman Natarajan | CSO | S - Sale | $18.00 | -1,238 | 188.8K | -0.7% | -$22.3K |
| M | 2024-07-16 | 2024-07-12+ | TRDA | Doshi Dipal | CEO, Dir | S - Sale | $17.84 | -1,900 | 334.5K | -0.6% | -$33.9K |
| 2024-07-10 | 2024-07-08 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $14.95 | -1,758 | 81.4K | -2% | -$26.3K | |
| 2024-06-14 | 2024-06-13 | TRDA | Doshi Dipal | CEO, Dir | S - Sale | $16.17 | -1,000 | 336.4K | -0.3% | -$16.2K | |
| D | 2024-06-05 | 2024-06-03 | TRDA | KIM PETER S | Dir | M - OptEx | $6.06 | +11.9K | 104.3K | +13% | +$72.2K |
| M | 2024-05-20 | 2024-05-16+ | TRDA | Sethuraman Natarajan | CSO | S - Sale | $15.16 | -19.0K | 190.1K | -9% | -$287.7K |
| M | 2024-05-20 | 2024-05-16+ | TRDA | Doshi Dipal | CEO, Dir | S - Sale | $15.04 | -3,000 | 337.4K | -0.9% | -$45.1K |
| 2024-05-16 | 2024-05-14 | TRDA | KIM PETER S | Dir | P - Purchase | $14.59 | +25.0K | 92.4K | +37% | +$364.8K | |
| M | 2024-05-10 | 2024-05-08+ | TRDA | KIM PETER S | Dir | P - Purchase | $14.14 | +4,476 | 65.2K | +7% | +$63.3K |
| 2024-04-10 | 2024-04-08 | TRDA | KIM PETER S | Dir | P - Purchase | $13.57 | +2,600 | 62.9K | +4% | +$35.3K | |
| 2024-04-01 | 2024-03-28 | TRDA | KIM PETER S | Dir | P - Purchase | $13.75 | +1,512 | 60.3K | +3% | +$20.8K | |
| M | 2024-03-26 | 2024-03-22+ | TRDA | KIM PETER S | Dir | P - Purchase | $13.58 | +9,048 | 56.1K | +19% | +$122.9K |
| M | 2024-03-21 | 2024-03-19+ | TRDA | KIM PETER S | Dir | P - Purchase | $12.81 | +2,732 | 49.1K | +6% | +$35.0K |
| D | 2024-03-19 | 2024-03-15 | TRDA | WENTWORTH KORY JAMES | CFO | M - OptEx | $2.10 | +9,000 | 83.2K | +12% | +$18.9K |
| 2024-03-08 | 2024-03-06 | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $12.32 | -1,826 | 137.2K | -1% | -$22.5K | |
| 2024-03-08 | 2024-03-06 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $12.31 | -4,086 | 74.2K | -5% | -$50.3K | |
| D | 2024-03-05 | 2024-03-01 | TRDA | Sethuraman Natarajan | CSO | A - Grant | $0.00 | +44.1K | 211.3K | +26% | $0 |
| DM | 2024-03-05 | 2024-03-04+ | TRDA | Sethuraman Natarajan | CSO | F - Tax | $12.50 | -2,266 | 209.0K | -1% | -$28.3K |
| D | 2024-03-05 | 2024-03-01 | TRDA | Doshi Dipal | CEO, Dir | A - Grant | $0.00 | +104.7K | 348.0K | +43% | $0 |
| DM | 2024-03-05 | 2024-03-04+ | TRDA | Doshi Dipal | CEO, Dir | F - Tax | $12.50 | -7,604 | 345.4K | -2% | -$95.1K |
| DM | 2024-03-05 | 2024-03-04+ | TRDA | Dowden Nathan J | Pres, COO | F - Tax | $12.50 | -2,238 | 139.0K | -2% | -$28.0K |
| DM | 2024-03-05 | 2024-03-01 | TRDA | Dowden Nathan J | Pres, COO | A - Grant | $0.00 | +93.1K | 81.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations